Continuous Glucose Monitoring Market Size & Growth Forecast 2027–2036, By Segments (Component, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Continuous Glucose Monitoring Market size was valued at USD 13.87 Billion in 2026 and is projected to grow at 16.95% CAGR from 2027 to 2036, reaching USD 66.39 Billion by 2036. The industry revenue for 2027 is estimated at USD 15.9 Billion.
Get more details on this report
Request Free Sample ReportContinuous Glucose Monitoring Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 49.93% in 2026, reflecting strong adoption of advanced diabetes technologies, developed healthcare infrastructure, and integration with digital health platforms.
- Asia Pacific is expanding fastest as diabetes prevalence rises and healthcare access, medical technology infrastructure, specialized care, and awareness of advanced monitoring improve.
Segment Momentum
- Sensors accounted for 53.53% of the market in 2026 and remain central due to real-time glucose measurement, improved accuracy, longer wear duration, and enhanced patient comfort.
- Home care settings held a 79.38% share in 2026 as patients increasingly prefer convenient self-monitoring, remote care support, and connected digital health solutions.
Market Expansion Drivers
- Rising global diabetes prevalence driving continuous glucose monitoring device adoption
- Government awareness initiatives accelerating uptake of diabetes monitoring solutions
- Integration of AI-enabled analytics improving real-time glucose trend prediction capabilities
Leading Market Participants
- Major players in the continuous glucose monitoring market include Abbott Laboratories (United States), Dexcom, Inc. (United States), Medtronic plc (Ireland), F. Hoffmann-La Roche Ltd. (Switzerland), Senseonics Holdings, Inc. (United States), Sinocare Inc. (China), A. Menarini Diagnostics S.r.l. (Italy), i-SENS, Inc. (South Korea), Medtrum Technologies Inc. (China), Zhejiang POCTech Co., Ltd. (China)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 13.87 Billion
- 2027 Estimated Market Size: USD 15.9 Billion
- Projected Market Size: USD 66.39 Billion by 2036
- Growth Forecast: 16.95% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Sensors (Component) | Home Care Settings (End Use)
- Emerging Opportunity Segment: Sensors (Component) | Home Care Settings (End Use)
Market Growth Drivers and Industry Trends
Rising global diabetes prevalence driving continuous glucose monitoring device adoption
The increasing number of individuals requiring long-term glucose management is strengthening demand for technologies that provide continuous and convenient monitoring. The continuous glucose monitoring market growth is driven by the growing need for real-time glucose tracking, enabling users and healthcare providers to better understand glucose fluctuations and make more informed treatment decisions. Continuous monitoring also reduces dependence on frequent conventional testing methods while supporting personalized disease management across diverse patient groups requiring ongoing glycemic assessment.
Government awareness initiatives accelerating uptake of diabetes monitoring solutions
Public health campaigns promoting diabetes screening, early diagnosis, and disease management are encouraging broader acceptance of advanced monitoring technologies. These initiatives will drive the continuous glucose monitoring market growth by improving awareness of the benefits of continuous glucose tracking among patients, caregivers, and healthcare professionals. Government-led educational programs, reimbursement support in applicable healthcare systems, and community outreach efforts further contribute to increased utilization of modern monitoring solutions within routine diabetes care.
Integration of AI-enabled analytics improving real-time glucose trend prediction capabilities
Advances in artificial intelligence are enhancing the ability of glucose monitoring systems to interpret continuously generated data and identify meaningful patterns. Within the continuous glucose monitoring market, AI-enabled analytics improve the value of monitoring devices by delivering predictive insights, recognizing emerging glucose trends, and supporting timely therapeutic decisions. Intelligent algorithms also assist users through personalized notifications, improved data visualization, and adaptive analysis that transforms raw glucose readings into more actionable clinical information.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global diabetes prevalence driving continuous glucose monitoring device adoption | 2.1% | High | North America, Europe, Asia Pacific | High | Near Term |
| Government awareness initiatives accelerating uptake of diabetes monitoring solutions | 1.7% | High | North America, Europe | High | Near Term |
| Integration of AI-enabled analytics improving real-time glucose trend prediction capabilities | 1.5% | Moderate | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for 49.93% of the continuous glucose monitoring market in 2026, reflecting strong adoption of advanced diabetes management technologies, developed healthcare infrastructure, and high awareness of continuous glucose monitoring among patients and healthcare professionals. The growing emphasis on proactive disease management and real-time glucose monitoring is encouraging a shift away from conventional intermittent testing toward connected monitoring solutions. Favorable access to diabetes care, expanding use of digital health technologies, and increasing integration of glucose data with mobile and remote-care platforms are further supporting adoption. In addition, the growing focus on personalized treatment and improved patient engagement is strengthening the role of continuous monitoring in long-term diabetes management.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to witness the fastest growth in the continuous glucose monitoring market, supported by the increasing prevalence of diabetes, improving healthcare access, and growing awareness of advanced glucose management technologies. Expanding urban populations and changing lifestyles are increasing the need for effective chronic disease management, while healthcare systems are gradually adopting digital and connected monitoring tools. Greater availability of specialized diabetes care and improving medical technology infrastructure are also making continuous monitoring more accessible to a broader patient population. Moreover, government efforts to strengthen chronic disease management and increasing interest in remote healthcare are expected to encourage wider adoption of continuous glucose monitoring solutions across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Digital Diabetes IntegrationThe U.S. continuous glucose monitoring market is advancing through broader integration with digital health platforms, insulin delivery systems, and remote patient monitoring. Healthcare providers across the U.S. are prioritizing real-time glucose data to improve diabetes management and support personalized treatment decisions.
Germany 🇩🇪
Clinical Care OptimizationGermany is expanding the use of continuous glucose monitoring across hospital care and outpatient diabetes management. The market in Germany is supported by demand for clinically validated devices that enhance treatment accuracy, patient adherence, and long-term disease monitoring.
Japan 🇯🇵
Precision Patient MonitoringJapan emphasizes compact and highly accurate continuous glucose monitoring systems suited to routine diabetes care and aging populations. Manufacturers in Japan are refining sensor performance and user convenience to encourage consistent glucose tracking in both clinical and home settings.
South Korea 🇰🇷
Connected Health AdoptionSouth Korea is strengthening the adoption of continuous glucose monitoring through connected healthcare ecosystems and mobile health applications. The market benefits from growing interest in wearable technologies that provide continuous data access for patients and healthcare professionals across diabetes management programs.
France 🇫🇷
Preventive Diabetes SupportFrance is encouraging wider use of continuous glucose monitoring to improve preventive diabetes care and long-term disease management. Healthcare providers in France are increasingly adopting sensor-based monitoring solutions that enable timely therapeutic adjustments and better patient engagement.
Italy 🇮🇹
Home Monitoring ExpansionItaly is increasing the use of continuous glucose monitoring across home-based diabetes management and specialist care. The market in Italy is focused on improving patient convenience, expanding access to wearable monitoring technologies, and supporting informed treatment decisions through continuous glucose insights.
Segment Leadership and Growth Trends
Continuous Glucose Monitoring Market Share (%), by Component, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportComponent Segment Analysis: Sensors (Largest & Fastest-Growing Segment)
The sensors segment dominated the continuous glucose monitoring market with a share of 53.53% in 2026 and also emerged as the fastest-growing component segment. Sensors form the core of continuous glucose monitoring systems by enabling real-time glucose measurement and providing the data required for accurate diabetes management. Continuous advancements in sensor accuracy, wear duration, and patient comfort have significantly improved user adoption, making sensors the most critical component within the ecosystem. The segment’s growth is further supported by increasing demand for personalized healthcare and continuous disease monitoring solutions. Rising prevalence of diabetes, growing awareness of proactive glucose management, and ongoing innovation in minimally invasive and user-friendly sensor technologies are strengthening demand. As healthcare providers and patients increasingly prioritize continuous monitoring over traditional testing methods, the sensor segment is expected to maintain its leading position.
End Use Segment Analysis: Home Care Settings (Largest & Fastest-Growing Segment)
In the continuous glucose monitoring market, the home care settings segment held the largest share of 79.38% in 2026 and was also the fastest-growing end-use segment. The widespread adoption of continuous glucose monitoring devices in home environments is driven by the convenience of self-monitoring and the ability to access real-time glucose data without frequent visits to healthcare facilities. Patients increasingly prefer home-based disease management solutions that support greater independence and improved quality of life. The segment is also benefiting from broader healthcare trends emphasizing remote patient monitoring and decentralized care delivery. Integration of continuous glucose monitoring systems with mobile applications, digital health platforms, and connected healthcare tools has enhanced accessibility and user engagement. These developments, combined with increasing awareness of diabetes management and preventive healthcare, continue to accelerate adoption within home care settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Component | Transmitters, Sensors, Receivers | Sensors | Sensors |
| End Use | Hospitals, Home Care Settings, Diagnostic Centres and Clinics, Others | Home Care Settings | Home Care Settings |
Competitive Landscape and Market Positioning
Top players in the continuous glucose monitoring market:
- Abbott Laboratories (United States)
- Dexcom, Inc. (United States)
- Medtronic plc (Ireland)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Senseonics Holdings, Inc. (United States)
- Sinocare, Inc. (China)
- A. Menarini Diagnostics S.r.l. (Italy)
- i-SENS, Inc. (South Korea)
- Medtrum Technologies, Inc. (China)
- Zhejiang POCTech Co., Ltd. (China)
Continuous glucose monitoring market competition is moving toward a broader race for accessibility, user experience, and integration with connected healthcare ecosystems. Device developers are focusing on improving convenience, accuracy, and seamless data sharing to support more personalized diabetes management approaches. As adoption expands beyond traditional clinical settings, competitive differentiation increasingly depends on creating solutions that fit everyday patient routines while enabling healthcare providers to make better-informed treatment decisions through continuous insights.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (United States) | |||||||
| Dexcom Inc. (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| F. Hoffmann-La Roche Ltd. (Switzerland) | |||||||
| Senseonics Holdings Inc. (United States) | |||||||
| Sinocare Inc. (China) | |||||||
| A. Menarini Diagnostics S.r.l. (Italy) | |||||||
| i-SENS Inc. (South Korea) | |||||||
| Medtrum Technologies Inc. (China) | |||||||
| Zhejiang POCTech Co. Ltd. (China) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| ALR Technologies | Jun-26 | ALR Technologies entered into a letter of intent to acquire 100% of CGM Medical Technology Singapore and the assets of CGM Medical Technology Shenzhen in a transaction valued at $45 million plus 200 million shares, strengthening its market positioning within the continuous glucose monitoring sector. |
| Signos | May-26 | Signos secured $20 million in funding from strategic participants including Dexcom, GV, and Blue Cross Blue Shield of Alabama, while establishing a commercial partnership with Dexcom to offer its glucose-informed weight management platform through Dexcom’s direct-to-consumer Stelo platform. |
| OSR Holdings | Oct-25 | OSR Holdings completed the acquisition of Woori IO, securing needle-free continuous glucose monitoring technology and expanding its competitive footprint in the growing CGM market landscape. |
| Abbott | Nov-24 | Abbott inaugurated a new continuous glucose monitoring sensor manufacturing facility in Ireland as part of a $465 million capital investment, significantly expanding production capacity for FreeStyle Libre 3 sensors to meet growing global demand. |
| Oura | Nov-24 | Oura received a $75 million strategic investment from Dexcom as part of a collaborative initiative aimed at integrating advanced smart ring applications with future continuous glucose monitoring capabilities and broader healthcare monitoring solutions. |
| ŌURA | Sep-24 | ŌURA acquired Veri, a specialist in metabolic health and continuous glucose monitoring, expanding its digital health ecosystem and incorporating specialized metabolic insight expertise into its wearable product portfolio. |
| Trinity Biotech | Feb-24 | Trinity Biotech acquired Waveform Technologies' continuous glucose monitoring assets for $12.5 million and partnered with Bayer to commercialize a CGM biosensor in China and India, accelerating its strategic expansion into wearable biosensor technologies. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Continuous Glucose Monitoring Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Type | Type 1 Diabetes Patients, Type 2 Diabetes Patients, Gestational Diabetes Patients, Prediabetes & At-Risk Patients |
| Glucose Monitoring Need | Intensive Glycemic Management, Routine Glycemic Monitoring, Hospital & Acute-Care Monitoring, Preventive & Wellness Monitoring |
| Reimbursement Model | Public Insurance, Private Insurance, Employer-Sponsored Coverage, Self-Pay |
Continuous Glucose Monitoring Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Reimbursement & Market Access Strategy |
|
| Patient Adoption & Retention Dynamics |
|
| Provider Integration Pathways |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of continuous glucose monitoring?
What is the projected value of the continuous glucose monitoring industry by 2036?
How is diabetes management transformation accelerating continuous glucose monitoring adoption?
How is AI integration enhancing the value of continuous glucose monitoring systems?
Why are sensors the leading component in continuous glucose monitoring systems?
What is driving adoption of continuous glucose monitoring in home care settings?
What supports North America's leadership in continuous glucose monitoring?
Why is Asia Pacific expected to see the fastest continuous glucose monitoring growth?
Which companies dominate the continuous glucose monitoring landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization